US4091101A
(en)
*
|
1977-06-15 |
1978-05-23 |
Merck & Co., Inc. |
6-(1-Piperazinyl)quinoxaline
|
DE3611343A1
(de)
*
|
1986-04-04 |
1987-10-08 |
Boehringer Mannheim Gmbh |
Heterocyclisch substituierte benzimidazole, verfahren zu ihrer herstellung, arzneimittel sowie zwischenprodukte
|
AU695936B2
(en)
*
|
1994-08-26 |
1998-08-27 |
Auckland Division Cancer Society Of New Zealand Inc |
Novel dna-targeted alkylating agents
|
EP0777656B1
(en)
*
|
1994-08-26 |
2004-04-14 |
Auckland Division Cancer Society Of New Zealand (Incorporated) |
Novel dna-targeted alkylating agents
|
US5767142A
(en)
*
|
1996-03-20 |
1998-06-16 |
Rutgers, The State University Of New Jersey |
Trisbenzimidazoles useful as topoisomerase I inhibitors
|
US5807874A
(en)
*
|
1995-05-17 |
1998-09-15 |
Rutgers, The State University Of New Jersey |
Trisbenzimidazoles useful as topoisomerase I inhibitors
|
AUPN449295A0
(en)
|
1995-07-28 |
1995-08-24 |
Inner And Eastern Health Care Network, The |
Radioprotectors
|
TR199900636T2
(xx)
*
|
1996-09-23 |
1999-10-21 |
Rutgers, The State University Of New Jersey |
Anti-t�m�r ajanlar� olarak ikameli/katk�l� heterosayk�llar.
|
US6140328A
(en)
*
|
1997-12-12 |
2000-10-31 |
Rutgers, The State University Of New Jersey |
Heterocyclic cytotoxic agents
|
IL136911A0
(en)
*
|
1997-12-31 |
2001-06-14 |
Univ Rutgers |
Heterocyclic topoisomerase poisons
|
US6063801A
(en)
|
1998-02-12 |
2000-05-16 |
Rutgers, The State University Of New Jersey |
Heterocyclic topoisomerase poisons
|
US6740650B2
(en)
|
1999-10-29 |
2004-05-25 |
Rutgers, The State University Of New Jersey |
Heterocyclic cytotoxic agents
|
MXPA04004606A
(es)
*
|
2001-11-14 |
2004-09-10 |
Univ Rutgers |
Venenos de topoisomerasa solubilizados.
|
WO2003041653A2
(en)
|
2001-11-14 |
2003-05-22 |
Rutgers, The State University |
Cytotoxic agents
|
ATE424200T1
(de)
*
|
2001-11-14 |
2009-03-15 |
Univ Rutgers |
Solubilisierte topoisomerase-gift-mittel
|
AU2002364953A1
(en)
*
|
2001-11-14 |
2003-06-17 |
Edmond J. Lavoie |
Topoisomerase poison agents
|
US20050119251A1
(en)
*
|
2001-12-21 |
2005-06-02 |
Jian-Min Fu |
Nicotinamide derivatives and their use as therapeutic agents
|
AU2003265405A1
(en)
*
|
2002-08-09 |
2004-02-25 |
Edmond J. Lavoie |
Nitro and amino substituted heterocycles as topoisomerase i targeting agents
|
WO2004014906A2
(en)
*
|
2002-08-09 |
2004-02-19 |
Rutgers, The State University |
Nitro and amino substituted dibenzonaphthyridines as topoisomerase agents
|
WO2004014918A1
(en)
|
2002-08-09 |
2004-02-19 |
Rutgers, The State University |
Nitro and amino substituted topoisomerase agents
|
AU2003290818A1
(en)
*
|
2002-11-12 |
2004-06-03 |
Edmond J. Lavoie |
Topoisomerase-targeting agents
|
EP2269610A3
(en)
*
|
2004-09-20 |
2011-03-09 |
Xenon Pharmaceuticals Inc. |
Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
|
AU2005286648A1
(en)
|
2004-09-20 |
2006-03-30 |
Xenon Pharmaceuticals Inc. |
Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors
|
CA2618646A1
(en)
*
|
2005-06-03 |
2007-11-15 |
Xenon Pharmaceuticals Inc. |
Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors
|
AU2007335185B2
(en)
*
|
2006-12-21 |
2013-06-27 |
Peter Maccallum Cancer Institute |
Radioprotector compounds and related methods
|
GB0821913D0
(en)
|
2008-12-02 |
2009-01-07 |
Price & Co |
Antibacterial compounds
|
EP2403856B1
(en)
|
2009-03-06 |
2012-12-19 |
Rutgers, The State University of New Jersey |
Methylenedioxybenzo [i]phenanthridine derivatives used to treat cancer
|
WO2010127363A1
(en)
|
2009-05-01 |
2010-11-04 |
Rutgers, The State University Of New Jersey |
Toposiomerase inhibitors
|
JP5712524B2
(ja)
*
|
2009-10-28 |
2015-05-07 |
Jsr株式会社 |
液晶配向剤および液晶表示素子
|
ES2568455T3
(es)
*
|
2010-06-01 |
2016-04-29 |
Summit Therapeutics Plc |
Compuestos para el tratamiento de enfermedad asociada a Clostridium difficile
|
JP6463631B2
(ja)
*
|
2011-06-09 |
2019-02-06 |
ライゼン・ファーマシューティカルズ・エスアー |
Gpr−119のモジュレータとしての新規化合物
|
GB201506660D0
(en)
|
2015-04-20 |
2015-06-03 |
Cellcentric Ltd |
Pharmaceutical compounds
|
GB201506658D0
(en)
|
2015-04-20 |
2015-06-03 |
Cellcentric Ltd |
Pharmaceutical compounds
|
WO2017125944A1
(en)
*
|
2016-01-23 |
2017-07-27 |
Jawaharlal Nehru University (Jnu) |
Broad spectrum antibacterial activity of novel bisbenzimidazoles targeting topoisomerase ia and the synergistic composition of bisbenzimidazole with efflux pump inhibitors against pathogenic bacteria
|
EP3442979A4
(en)
|
2016-04-04 |
2019-12-18 |
Rutgers, the State University of New Jersey |
topoisomerase poisons
|